Skip to main content
. 2002 Mar;70(3):1069–1074. doi: 10.1128/IAI.70.3.1069-1074.2002

TABLE 1.

Effects of intranasal prophylaxis with P. carinii-specific MAbs on the outcome of PCP in SCID mice

Expt Antibody prepn No. of mice No. of P. carinii-positive-micea No. of P. carinii cells/mouse (log10)
1 Anti-gpA pool 5 2 4.60 ± 0.76b
Anti-P. carinii pool 5 0 <4.06 ± 0.00c
Saline 5 5 5.78 ± 0.38
2 4F11 + 1G4 8 0 <4.30 ± 0.00d
Anti-30-70-kDa pool 8 3 4.59 ± 0.52
IgM- and IgG-negative control 8 8 5.04 ± 0.18
3 1G4 8 7 5.44 ± 0.64e
4F11 8 8 5.79 ± 1.20
4F11(G1) 8 8 6.16 ± 1.51
Anti-30-70-kDa pool 8 8 6.43 ± 0.41
IgM- and IgG-negative control 8 8 6.43 ± 1.21
4 1G4 8 1 3.87 ± 0.32d
4F11 7 1 3.99 ± 0.61d
4F11(G1) 7 1 4.14 ± 1.00b
IgG-negative control 7 7 5.05 ± 0.55d
IgM-negative control 6 6 6.19 ± 0.39
a

Number of organisms detectable by microscopy.

b

P ≤ 0.03 compared to value for IgG control.

c

P = 0.008.

d

P < 0.001 compared to value for IgM control.

e

P = 0.01 compared to values obtained with control MAbs.